⌘K
Loading ticker…
As of 2026-08-25, Medicus Pharma Ltd. Common Stock (MDCX) has a 3-month relative strength percentile of 30 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 31. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 10.1%, relative volume 0.46×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
MDCX is in a stage 4 downtrend, week 5. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -26.4% / -69.8%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
MDCX appears in 1 ETF as of Sep 2025: IWC at 0.00% weight, $35K notional.
Held by 1 ETFs · $35K across latest filings · largest weight 0.00% (IWC).
Top 1 by value, from SEC N-PORT-P filings dated Sep 2025.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| IWC | 0.00% | $35K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MDCX Jan avg: -7.61% median: -7.61% win: 50% σ: 20.66% n: 2 2024-11-15 → 2026-07-31 | MDCX Feb avg: 41.02% median: 41.02% win: 100% σ: 17.60% n: 2 2024-11-15 → 2026-07-31 | MDCX Mar avg: -38.38% median: -38.38% win: 0% σ: 44.71% n: 2 2024-11-15 → 2026-07-31 | MDCX Apr avg: -12.71% median: -12.71% win: 50% σ: 36.38% n: 2 2024-11-15 → 2026-07-31 | MDCX May avg: -2.62% median: -2.62% win: 50% σ: 51.94% n: 2 2024-11-15 → 2026-07-31 | MDCX Jun avg: 17.51% median: 17.51% win: 100% σ: 0.36% n: 2 2024-11-15 → 2026-07-31 | MDCX Jul avg: -28.03% median: -28.03% win: 0% σ: 14.57% n: 2 2024-11-15 → 2026-07-31 | MDCX Aug avg: -21.14% median: -21.14% win: 0% σ: 0.00% n: 1 2024-11-15 → 2026-07-31 (current) | MDCX Sep avg: 19.33% median: 19.33% win: 100% σ: 0.00% n: 1 2024-11-15 → 2026-07-31 | MDCX Oct avg: 5.40% median: 5.40% win: 100% σ: 0.00% n: 1 2024-11-15 → 2026-07-31 | MDCX Nov avg: -4.05% median: -4.05% win: 50% σ: 8.18% n: 2 2024-11-15 → 2026-07-31 | MDCX Dec avg: -20.16% median: -20.16% win: 0% σ: 14.56% n: 2 2024-11-15 → 2026-07-31 |